Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Badalona
Clinical trial register · Spain

Clinical Trials in Badalona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca35 Janssen Research & Development, LLC33 Merck Sharp & Dohme LLC24 AbbVie19 Bristol-Myers Squibb17
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Badalona

562 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
AstraZeneca
Phase 3
1,063
Badalona, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2018-11-16
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Badalona, Galdakao, Barcelona, Madrid, Tarragona
2018-11-06
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Badalona, Barcelona
2018-10-30
Active, closed
PETHEMA Foundation
Phase 3
462
A Coruña, Albacete, Alicante, Badalona, Barcelona, Bilbao, Cáceres, Córdoba
2018-10-22
Active, closed
Tesaro, Inc.
Phase 3
1,400
Ávila, Badalona, Barcelona, Girona, Jaén, Madrid, Santiago de Compostela, Toledo
2018-10-11
Active, closed
AbbVie
Phase 2
270
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alcorcón, Ávila, Barcelona, Madrid, Málaga
2018-10-10
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Badalona, Barcelona, Salamanca, Valencia
2018-10-04
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
DrugDaromun
Philogen S.p.A.
Phase 3
186
Badalona, Barcelona, Las Palmas de Gran Canaria, Donostia / San Sebastian, Madrid, Málaga, Murcia, Seville
2018-09-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Palma, Palma de Mallorca, L'Hospitalet de Llobregat, San Sebastian- Donostia, Santander, Badalona, Barcelona, Santiago de Compostela
2018-08-21
Active, closed
Gilead Sciences
Phase 2
502
Badalona, Barcelona, Córdoba, Las Palmas, Madrid, Majadahonda, Manresa, Ourense
2018-08-13
Active, closed
PETHEMA Foundation
Phase 2
62
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona
2018-07-15
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Pamplona, Badalona, Barcelona, Madrid
2018-06-26
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Badalona, Ávila, Alcorcón, Barcelona, Burgos, Madrid, Murcia, Seville
2018-06-21
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pamplona, Badalona, Barcelona, Madrid, Santiago de Compostela
2018-05-21
Recruiting
BioInvent International AB
Phase 1/2
140
Badalona, Barcelona, Madrid, Murcia, Seville
2018-05-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Badalona, Esplugues de Llobregat, Barcelona, Madrid, Tortosa
2018-04-23
Recruiting
Fundació Institut Germans Trias i Pujol
Observational
200
Badalona, Esplugues de Llobregat, Barcelona
2018-04-19
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Badajoz, Badalona, Barcelona, Cáceres, Córdoba, Granada, Jaén, Las Palmas de Gran Canaria
2018-03-23
Recruiting
Spanish Breast Cancer Research Group
Observational
8,000
Pamplona, Avilés, San Cristóbal de La Laguna, A Coruña, Albacete, Alicante, Badajoz, Badalona
2018-01-18
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Badalona, Barcelona, Santander, Madrid, Seville, Valencia
2017-12-29
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Badalona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca
2017-12-16
Active, closed
Gilead Sciences
Phase 3
340
Badalona, Barcelona, Horcajo de la Sierra, Madrid, Málaga, Santander
2017-12-12
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
61
Badalona, Madrid, Málaga, Salamanca, Valencia
2017-12-01
Active, closed
BeiGene
Phase 3
590
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Valencia, Zaragoza
2017-10-31
Active, closed
ViiV Healthcare
Phase 3
1,049
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2017-10-27
Recruiting
Apollomics Inc.
Phase 2
497
Badalona, Barcelona, Madrid, Valencia
2017-09-27
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo
2017-09-05
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
DrugAvelumab
Transgene
Phase 1/2
143
Badalona, Granada, Madrid, Málaga, Valencia
2017-09-01
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Santiago de Compostela, Palma de Mallorca, Badalona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville, Valencia
2017-06-26
Active, closed
MedSIR
Phase 2
377
Badalona, L'Hospitalet de Llobregat, Castelló, Jaén, Málaga, Reus, A Coruña, Barcelona
2017-06-26
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Badalona, Majadahonda, Barcelona, Madrid, Salamanca
2017-05-22
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Badalona, Barcelona, Pamplona, Salamanca
2017-05-16
Active, closed
Acerta Pharma BV
Phase 3
635
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Seville, Valencia
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Badalona, L'Hospitalet de Llobregat, Santander, Barcelona, Madrid
2017-02-21
Active, closed
Acerta Pharma BV
Phase 3
310
Badalona, Madrid, Majadahonda, Salamanca, Santander, Valencia
2017-02-02
Active, closed
AbbVie
Phase 2
120
Badalona, Barcelona, Madrid
2017-01-19
Active, closed
AstraZeneca
Phase 1
117
Badalona, Barcelona, Madrid
2016-12-28
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Active, closed
ViiV Healthcare
Phase 3
618
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2016-10-28
Recruiting
Thoracic Tumours Register
NCT02941458Thoracic Tumors
Spanish Lung Cancer Group
Observational
10,000
Ferrol, Albacete, Alcoy, Alicante, Elche, Elda, Badalona, Barcelona
2016-07-21
Active, closed
Tesaro, Inc.
Phase 3
733
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Elche Alicante, Girona, Madrid, Seville
2016-07-11
Active, closed
Geron Corporation
Phase 2/3
289
Cadiz, Majadahonda, Seville, Valencia, Barakaldo, Badalona, Barcelona, Madrid
2016-01-12
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
A Coruña, Alicante, Badalona, Barcelona, Burgos, Castellon, Cáceres, Córdoba
2015-08
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
Acerta Pharma BV
Phase 2
124
Badalona, Pamplona
2015-03-02
Active, closed
ViiV Healthcare
Phase 3
371
Badalona, Barcelona, Madrid, Seville
2015-02-23
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Badalona, Barcelona, Madrid, Palma de Mallorca, Pamplona, Salamanca, Seville
2014-11
Active, closed
AbbVie
Observational
1,446
A Coruña, Ferrol, Santiago de Compostela, Palma de Mallorca, Badalona, Esplugues de Llobregat, Sabadell, Leganés
2014-08-28
Recruiting
Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes
NCT07746258Cutaneous Squamous Cell Carcinoma (CSCC)
Germans Trias i Pujol Hospital
Not applicable
142
Badalona
2014-07-25
Active, closed
AstraZeneca
Phase 3
1,837
A Coruña, Ávila, Badajoz, Badalona, Barcelona, Castellon, Cáceres, Córdoba
2014-04-22
Active, closed
University of Sydney
Phase 3
802
Badalona, Donostia / San Sebastian, Salamanca
2014-03
Active, closed
UNICANCER
Phase 3
1,173
Badalona, Barcelona, Girona, Madrid, Manresa, Málaga, Sabadell, Salamanca
2013-11-13
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
A Coruña, Badalona, Barcelona, Castellon, Girona, Guadalajara, Jerez de la Frontera, Las Palmas de Gran Canaria
2013-10-14
Active, closed
AbbVie
Observational
8,250
A Coruña, Ferrol, Santiago de Compostela, Elche, Sant Joan d'Alacant, Manacor, Palma de Mallorca, Badalona
2013-04-29
Active, closed
UNICANCER
Phase 3
415
Badalona
2011-04-26
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
L'Hospitalet de Llobregat, Badalona, Barcelona, Valencia
2009-09
Recruiting
Radboud University Medical Center
Observational
176
Badalona, Granada
2009-02
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Badalona, Barcelona, Madrid, Valencia, Vitoria-Gasteiz
1994-01
Rows per page Showing 501–562 of 562
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/badalona?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 562 of those studies with a site in Badalona.

How many clinical trials are recruiting in Badalona?

257 of the 562 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 13 have not yet opened recruitment, 285 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.